Evaluation of the Safety and Efficacy of Ang-(1-7) to Enhance Cognitive Function in Participants Undergoing CABG

NCT03252093 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Funding ended

Conditions

Coronary Artery Bypass Surgery
Cognitive Impairment

Interventions

DRUG: Angiotensin-(1-7)
DRUG: Placebo for Angiotensin-(1-7)

Sponsor

University of Arizona

Collaborators

[object Object]
[object Object]